Deep Intelligent Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$78.1M
- Investors
-
12
Deep Intelligent Pharma General Information
Description
Developer of artificial intelligence-based drug discovery and pharmaceutical research software designed to support data-driven decision-making in life science. The company applies deep learning and natural language processing to extract, normalize, and analyze biomedical and pharmaceutical data from diverse structured and unstructured sources, enabling pharmaceutical companies, biotechnology firms, and research institutions to reduce manual information processing, prioritize R&D opportunities, and improve the efficiency and consistency of discovery and development activities.
Contact Information
Website
www.dip-ai.comCorporate Office
- 3 Temasek Avenue
- Suite 21-00, Centennial Tower
- Singapore
- Singapore
Corporate Office
- 3 Temasek Avenue
- Suite 21-00, Centennial Tower
- Singapore
- Singapore
Deep Intelligent Pharma Timeline
Deep Intelligent Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 02-Feb-2026 | $78.1M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series D) | 11-Dec-2025 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B1) | 01-Dec-2019 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 09-Oct-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 01-May-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Dec-2017 | Completed | Startup | |||
| 2. Seed Round | 23-Nov-2017 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Deep Intelligent Pharma Signals
Deep Intelligent Pharma Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jinyi Capital | Venture Capital | Minority | ||
| Kaitai Capital | Venture Capital | Minority | ||
| NewDing Capital | Venture Capital | Minority | ||
| Trustar Capital | PE/Buyout | Minority | ||
| Xinchen Capital | Venture Capital | Minority |
Deep Intelligent Pharma Investments (2)
Deep Intelligent Pharma’s most recent deal was a Later Stage VC with iMBIORAY for . The deal was made on 05-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| iMBIORAY | 05-Feb-2026 | Later Stage VC | Drug Discovery | ||
| Jinkebo Biotechnology | 28-Nov-2025 | Early Stage VC | Biotechnology |
Deep Intelligent Pharma FAQs
-
When was Deep Intelligent Pharma founded?
Deep Intelligent Pharma was founded in 2017.
-
Where is Deep Intelligent Pharma headquartered?
Deep Intelligent Pharma is headquartered in Singapore, Singapore.
-
What is the size of Deep Intelligent Pharma?
Deep Intelligent Pharma has 100 total employees.
-
What industry is Deep Intelligent Pharma in?
Deep Intelligent Pharma’s primary industry is Discovery Tools (Healthcare).
-
Is Deep Intelligent Pharma a private or public company?
Deep Intelligent Pharma is a Private company.
-
What is Deep Intelligent Pharma’s current revenue?
The current revenue for Deep Intelligent Pharma is .
-
How much funding has Deep Intelligent Pharma raised over time?
Deep Intelligent Pharma has raised $143M.
-
Who are Deep Intelligent Pharma’s investors?
Jinyi Capital, Kaitai Capital, NewDing Capital, Trustar Capital, and Xinchen Capital are 5 of 12 investors who have invested in Deep Intelligent Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process